Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.

Scandinavian cardiovascular journal : SCJ - 1 Aug 2014

Kylhammar David, Persson Liselotte, Hesselstrand Roger, Rådegran Göran

Abstract excerpt

OBJECTIVES: To investigate survival, treatment escalation, effects of first-line single- and first-line combination therapy and prognostic markers in idiopathic- (IPAH), hereditary- (HPAH) and connective tissue disease-associated (CTD-PAH) pulmonary arterial hypertension (PAH). DESIGN: Retrospect...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Arterial Pressure
Share to Exercise Tolerance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Familial Primary Pulmonary Hypertension

Share to Hypertension, Pulmonary

Share to Pulmonary Artery

Share to Recovery of Function

Share to Vascular Resistance

Source

Identifiers

PMID: 24912571
DOI: 10.3109/14017431.2014.931595

Genes

PAH
MRAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-24912571-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.PMID 24912571Read ↗

Idiopathic pulmonary arterial hypertension.Semantic proximity Read ↗

The 6th World Symposium on Pulmonary Hypertension: what’s old is newSemantic proximity Read ↗

Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?Semantic proximity Read ↗

New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbidities.Semantic proximity Read ↗

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertensionSemantic proximity Read ↗

Management of Pulmonary Arterial Hypertension. Current Strategies and Future ProspectsSemantic proximity Read ↗

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era.Semantic proximity Read ↗

Cluster analysis reveals three clinical phenotypes of pulmonary artery hypertension associated with connective tissue diseases: insights into inflammation and immunity.Semantic proximity Read ↗

Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue DiseasesSemantic proximity Read ↗

Pulmonary hypertension in adults with congenital heart disease. Clinical phenotypes and outcomes in the advanced pulmonary vasodilator era.Semantic proximity Read ↗

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.Semantic proximity Read ↗

Idiopathic pulmonary arterial hypertension: current state of play and new treatment modalities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.